Menlo Advisors’s PetMed Express PETS Stock Holding History

Menlo Advisors’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-86,865	Closed	-$1.56M	–	36
2019 Q3	$1.56M	Sell	86,865 -2,105	-2%	-$34.8K	1.09%	26
2019 Q2	$1.39M	Sell	88,970 -3,360	-4%	-$66.1K	0.96%	28
2019 Q1	$2.1M	Sell	92,330 -1,060	-1%	-$23.9K	1.5%	27
2018 Q4	$2.17M	Sell	93,390 -3,670	-4%	-$98K	1.69%	25
2018 Q3	$3.2M	Buy	+97,060	New	+$3.63M	2.16%	22

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Menlo Advisors's PETS Position: Q4 2019 in Review

Menlo Advisors sold out of PetMed Express (PETS) in Q4 2019, closing a stake of 86,865 shares — an estimated $1.56M sold.

Menlo Advisors first reported a position in PETS in Q3 2018 and held it in 5 quarters. The position peaked at $3.2M in Q3 2018. 189 funds tracked by Wall St. Rank hold PETS as of Q4 2019.

Menlo Advisors reported no remaining PetMed Express position as of Q4 2019 after selling out during the quarter.
Menlo Advisors sold 86,865 PetMed Express shares in Q4 2019, an estimated $1.56M.
Menlo Advisors first reported a position in PetMed Express in Q3 2018 and held it in 5 quarters.
Menlo Advisors's PetMed Express position peaked at $3.2M in Q3 2018.
189 funds tracked by Wall St. Rank held PetMed Express as of Q4 2019.

Based on Menlo Advisors's 13F filing for Q4 2019, filed 7 Jan 2020.